AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: Valar LabsClear filter
industryBusiness Wire

Valar Labs Wins FDA Breakthrough Nod for Vesta Bladder Risk Stratify Dx

Valar Labs has received FDA Breakthrough Device Designation for its Vesta Bladder Risk Stratify Dx test, signaling confidence in AI-driven bladder cancer risk assessment. The recognition reinforces a broader trend: regulators are increasingly engaging with narrow, clinically grounded AI diagnostics rather than generalized medical AI claims.

Valar Labsbladder cancerFDA Breakthrough DeviceAI diagnostics

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.